A comparison of parametric propensity score-based methods for causal inference with multiple treatments and a binary outcome

被引:10
作者
Yu, Youfei [1 ]
Zhang, Min [1 ]
Shi, Xu [1 ]
Caram, Megan E. V. [2 ,3 ,4 ]
Little, Roderick J. A. [1 ]
Mukherjee, Bhramar [1 ]
机构
[1] Univ Michigan, Sch Publ Hlth, Dept Biostat, 1420 Washington Hts, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Med Sch, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI USA
[3] VA Ann Arbor Healthcare Syst, Vet Affairs VA Hlth Serv Res & Dev, Ctr Clin Management & Res, Ann Arbor, MI USA
[4] Univ Michigan, Sch Med, Inst Healthcare Policy & Innovat, Ann Arbor, MI USA
基金
美国国家科学基金会;
关键词
causal inference; comparative effectiveness research; electronic health records; multiple treatment comparison; propensity score; SYSTEMIC TREATMENT; INCREASED SURVIVAL; SUBCLASSIFICATION; MULTIVARIATE; PERFORMANCE; STRATEGIES; CANCER;
D O I
10.1002/sim.8862
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We consider comparative effectiveness research (CER) from observational data with two or more treatments. In observational studies, the estimation of causal effects is prone to bias due to confounders related to both treatment and outcome. Methods based on propensity scores are routinely used to correct for such confounding biases. A large fraction of propensity score methods in the current literature consider the case of either two treatments or continuous outcome. There has been extensive literature with multiple treatment and binary outcome, but interest often lies in the intersection, for which the literature is still evolving. The contribution of this article is to focus on this intersection and compare across methods, some of which are fairly recent. We describe propensity-based methods when more than two treatments are being compared, and the outcome is binary. We assess the relative performance of these methods through a set of simulation studies. The methods are applied to assess the effect of four common therapies for castration-resistant advanced-stage prostate cancer. The data consist of medical and pharmacy claims from a large national private health insurance network, with the adverse outcome being admission to the emergency room within a short time window of treatment initiation.
引用
收藏
页码:1653 / 1677
页数:25
相关论文
共 69 条
  • [1] Large sample properties of matching estimators for average treatment effects
    Abadie, A
    Imbens, GW
    [J]. ECONOMETRICA, 2006, 74 (01) : 235 - 267
  • [2] Matching on the Estimated Propensity Score
    Abadie, Alberto
    Imbens, Guido W.
    [J]. ECONOMETRICA, 2016, 84 (02) : 781 - 807
  • [3] Utilizing propensity scores to estimate causal treatment effects with censored time-lagged data
    Anstrom, KJ
    Tsiatis, AA
    [J]. BIOMETRICS, 2001, 57 (04) : 1207 - 1218
  • [4] The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studies
    Austin, Peter C.
    [J]. STATISTICS IN MEDICINE, 2010, 29 (20) : 2137 - 2148
  • [5] Some Methods of Propensity-Score Matching had Superior Performance to Others: Results of an Empirical Investigation and Monte Carlo simulations
    Austin, Peter C.
    [J]. BIOMETRICAL JOURNAL, 2009, 51 (01) : 171 - 184
  • [6] Applications of propensity score methods in observational comparative effectiveness and safety research: where have we come and where should we go?
    Borah, Bijan J.
    Moriarty, James P.
    Crown, William H.
    Doshi, Jalpa A.
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2014, 3 (01) : 63 - 78
  • [7] Patient and Provider Variables Associated with Systemic Treatment of Advanced Prostate Cancer
    Caram, Megan E. V.
    Wang, Shikun
    Tsao, Phoebe
    Griggs, Jennifer J.
    Miller, David C.
    Hollenbeck, Brent K.
    Lin, Paul
    Mukherjee, Bhramar
    [J]. UROLOGY PRACTICE, 2019, 6 (04) : 234 - 242
  • [8] Factors Associated With Use of Sipuleucel-T to Treat Patients With Advanced Prostate Cancer
    Caram, Megan E. V.
    Ross, Ryan
    Lin, Paul
    Mukherjee, Bhramar
    [J]. JAMA NETWORK OPEN, 2019, 2 (04)
  • [9] Temporal and geographic variation in the systemic treatment of advanced prostate cancer
    Caram, Megan E. V.
    Estes, Jason P.
    Griggs, Jennifer J.
    Lin, Paul
    Mukherjee, Bhramar
    [J]. BMC CANCER, 2018, 18
  • [10] THE NUMBER NEEDED TO TREAT - A CLINICALLY USEFUL MEASURE OF TREATMENT EFFECT
    COOK, RJ
    SACKETT, DL
    [J]. BRITISH MEDICAL JOURNAL, 1995, 310 (6977) : 452 - 454